8 April 2025
Impact of PEPFAR funding cuts in harm reduction in Zambia
Share this post
related content
This information note has been compile by Harm Reduction International (HRI) to highlight the impact of US funding cuts on harm reduction in Zambia
For updates or additional information, please feel free to contact us at hrfunding@hri.global
You can download the document to see references.
Last updated: 10 March 2025
Epidemiological data
1.1 People who use drugs, HIV and viral hepatitis
- There are an estimated 30,000 people who inject drugs in the country
- HIV prevalence among people who inject drugs is 24%.
- Hepatitis B prevalence among people who inject drugs is 3.2%.
1.2 HIV prevention and treatment and harm reduction
- National coverage of HIV prevention programs for people who inject drugs is 37.7%.
- The ART coverage for people who inject drugs living with HIV is only 4%.
- 48% of people who inject drugs had HIV testing and aware of their HIV status in 2019.
- The is explicit supportive reference to harm reduction in national policy documents.
Harm reduction programme gaps due to PEPFAR funding cuts
- A total of 32 drop-in centres that provide HIV services to over 20,000 key populations living with HIV on ART in 7 out of 10 provinces have been shut down.
- HIV services are at a complete standstill in the six districts of the Northern Province, where Right to Health is the only USG implementing partner.
Don't miss our events and publications
Subscribe to our newsletter